Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yili Hu
Institution:
Nanjing University of Chinese Medicine
Observed institution:
Nanjing University of Chinese Medicine
ORCID:
0009-0009-9741-1204
Observed ORCID:
0009-0009-9741-1204
OpenAlex ID:
A5035842036
A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer
2023
·
Anni Hu
, Hang Wang
, et al.
·
Redox Biology
·
54
NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer
2024
·
Xinzhi Wang
, Yi Qu
, et al.
·
Cancer Research
·
32
Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia
2023
·
Yefan Han
, Anni Hu
, et al.
·
Pharmacological Research
·
7
Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia
2022
·
Yin Feng
, Yefan Han
, et al.
·
Acta Pharmaceutica Sinica B
·
5
PDF
Supplementary Table S6 from NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer
2024
·
Xinzhi Wang
, Yi Qu
, et al.
Supplementary Data 1 from NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer
2024
·
Xinzhi Wang
, Yi Qu
, et al.
Data from NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer
2024
·
Xinzhi Wang
, Yi Qu
, et al.
Show more works
View as search
Works count:
7
Citation count:
98
H-index:
4
I10-index:
2
Year
Topic
Type